Developing a Telehealth + mHealth Cannabis Use Intervention for Young Adults
Part of paid clinical trials in Boston, Massachusetts.
- Sponsor
- Boston Children's Hospital
- Study ID
- NCT06661031
- Status
- Enrolling By Invitation
Conditions
- Cannabis Use Disorder
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 26 Years
- Healthy Volunteers
- Not accepted
Interventions
- Motivational Enhancement Therapy plus Ecological Momentary Intervention — BEHAVIORALTwo Motivational Enhancement Therapy (MET) sessions (1st, \~45 minutes; 2nd, \~30 minutes) between counselor and participant occur one week apart. MET sessions are personalized, interactive, face-to-face, and delivered according to a manual. MET session discussion topics include triggers for cannabis use, life goals/values, and development of a change plan. Participants then complete a 2-week Ecological Momentary Intervention (EMI) period. Survey prompts are sent 4x/day (3x/day at quasi-randomized times, 1x/day at fixed time; \~2 mins each) that ask about the participant's recent cannabis use. Depending on answers reported, the participant can receive tailored messages that support their self-efficacy and prompt use of coping strategies.
- Enhanced Usual Care — BEHAVIORALParticipants meet with a study counselor 1-on-1 via videoconference to review a brochure containing cannabis information and treatment resources.
Study Details
The goal of this clinical trial is to determine 1) feasibility of the MOMENT-V intervention for cannabis use disorder in young adults, 2) feasibility of conducting the trial remotely, and 3) whether the MOMENT-V intervention reduces cannabis use frequency and problems. Researchers will compare the MOMENT-V intervention to usual care enhanced by a counselor meeting. Participants will either meet with a counselor two times and use an app on their phone for two weeks, or meet with a counselor briefly one time. All participants will be asked to complete electronic surveys, interviews with a research assistant, and saliva drug testing at home over three months.
Key Dates
- Start date
- Dec 10, 2024
- Status verified
- Dec 2025
- Primary completion
- May 31, 2027
- Completion
- May 31, 2027
Study Design
- Enrollment
- 65 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Other: Enhanced Usual Care armParticipants meet with a study counselor 1-on-1 via videoconference to review a brochure containing cannabis information and treatment resources.
- Experimental: Intervention armParticipants meet with a counselor 1-on-1 via videoconference and receive MOMENT-V (mHealth intervention involving 2 Motivational Enhancement Therapy \[MET\] sessions with a trained counselor and 2 weeks of smartphone-based Ecological Momentary Assessment \[EMI\]).
- No Intervention: Oral fluid test pilotPrior to RCT, single-arm pilot to test feasibility and acceptability of remote oral fluid testing.
Primary Outcome Measure
Intervention completion [ Time Frame: At week 3 (Upon completion of 2-week EMI period) ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Boston Children's Hospital | Boston | Massachusetts | 02115 | - |
Find similar trials in Boston, MA
Related Studies
- Integrated Treatment for Enhancing Growth in Recovery During AdolescenceRecruiting · Massachusetts General Hospital · Farmington, Connecticut
- Evaluation of Suvorexant for Reduction of Brain Reactivity in Patients With Cannabis Use Disorder (Pilot Study)PHASE4 · Recruiting · Massachusetts General Hospital · Boston, Massachusetts
- Preliminary Efficacy Trial of a Digital Intervention for Depression and Cannabis UseRecruiting · Massachusetts General Hospital · Boston, Massachusetts
- Study of Oral Fluid Testing ApproachRecruiting · Boston Children's Hospital · Boston, Massachusetts